DxTerity Diagnostics
DxTerity Gets New York State Authorization for Systemic Lupus Erythematosus Test
The test is used to identify patients less likely to respond to standard treatment and more likely to develop a severe kidney disorder.
Bristol Myers Squibb, LabCorp, NeoGenomics, Others Join Consortium to Improve COVID-19 Testing
The consortium seeks to accelerate research and clinical diagnostic applications through collaboration with the ultimate goal of improving COVID-19 testing.
DxTerity Diagnostics, Patients Choice Get FDA Emergency Use Authorizations for Coronavirus Tests
The two tests, both of which use RT-PCR technology to detect multiple viral targets, may be performed only by their respective developers.
DxTerity, Texas Department of State Health Services Coronavirus Molecular Tests Get FDA EUAs
Under the Emergency Use Authorizations, the RT-PCR tests may be performed by any laboratory CLIA-certified to perform high-complexity testing.
DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
The device is designed to stabilize RNA and DNA from fingerstick blood at room temperature for up to two weeks so that it can be mailed to a lab for analysis.